30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Relmada Therapeutics Inc (RLMD)

Track

The most recent insider trading activity occurred on December 15, 2025, with the Chief Executive Officer and Chief Financial Officer making significant purchases. Prior to this, in November 2025, several executives, including the CEO and CFO, also engaged in substantial buying activity. These transactions represent consistent buying by key leadership.
Stock chart
Ticker: RLMD Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
TRAVERSA SERGIO
Chief Executive Officer
1 purchase — total 113,300 USD
Buy 15 Dec 2025
Value US$4,220,052.78 | Price 315.92 | Shares 90,407
Buy 15 Dec 2025
Value US$4,586,390.91 | Price 447.83 | Shares 83,255
Buy 5 Nov 2025
Value US$1,100,000.00 | Price 2.20 | Shares 500,000
Buy 5 Nov 2025
Value US$299,200.00 | Price 2.20 | Shares 136,000
Buy 5 Nov 2025
Value US$198,000.00 | Price 2.20 | Shares 90,000
Buy 5 Nov 2025
Value US$599,500.00 | Price 2.20 | Shares 272,500
Buy 28 Aug 2025
Value US$41,422.24 | Price 0.74 | Shares 55,976
Buy 27 Aug 2025
Value US$86,734.85 | Price 0.67 | Shares 129,455
Buy 26 Aug 2025
Value US$49,937.90 | Price 0.62 | Shares 80,545
Buy 20 May 2025
Value US$31,422.00 | Price 0.52 | Shares 60,000
Buy 20 May 2025
Value US$82,246.33 | Price 0.56 | Shares 147,686
Buy 19 May 2025
Value US$43,686.00 | Price 0.49 | Shares 90,000
Buy 19 May 2025
Value US$14,994.00 | Price 0.50 | Shares 30,000
Buy 16 May 2025
Value US$22,100.00 | Price 0.44 | Shares 50,000
Buy 16 May 2025
Value US$77,472.37 | Price 0.45 | Shares 172,314
Buy 16 May 2025
Value US$86,060.00 | Price 0.43 | Shares 200,000
Buy 16 May 2025
Value US$103,330.10 | Price 0.45 | Shares 228,961
Buy 11 Sep 2024
Value US$71,154.00 | Price 2.95 | Shares 24,120
Buy 11 Sep 2024
Value US$153,706.93 | Price 2.99 | Shares 51,407
Buy 10 Sep 2024
Value US$57,652.14 | Price 2.73 | Shares 21,118
Buy 10 Sep 2024
Value US$90,788.50 | Price 2.75 | Shares 33,014
Buy 9 Sep 2024
Value US$20,894.70 | Price 2.55 | Shares 8,194
Buy 9 Sep 2024
Value US$150,619.09 | Price 2.71 | Shares 55,579
Buy 9 Sep 2024
Value US$64,750.00 | Price 2.59 | Shares 25,000
Buy 9 Sep 2024
Value US$33,280.00 | Price 2.56 | Shares 13,000
Proposed sale 20 Feb 2024
Value US$442,494.10 | Price 5.90 | Shares 74,999
Buy 31 Jan 2024
Value US$55,429.12 | Price 4.05 | Shares 13,670
Buy 31 Jan 2024
Value US$109,752.13 | Price 4.00 | Shares 27,460
Buy 31 Jan 2024
Value US$27,943.44 | Price 4.06 | Shares 6,875
Buy 30 Jan 2024
Value US$56,052.65 | Price 3.87 | Shares 14,500
Buy 30 Jan 2024
Value US$159,949.40 | Price 3.90 | Shares 40,999
Buy 30 Jan 2024
Value US$58,323.00 | Price 3.89 | Shares 15,000
Buy 29 Jan 2024
Value US$39,438.36 | Price 3.65 | Shares 10,800
Buy 29 Jan 2024
Value US$117,036.03 | Price 3.71 | Shares 31,541
Buy 29 Jan 2024
Value US$39,450.24 | Price 3.65 | Shares 10,800
Buy 23 May 2023
Value US$31,800.00 | Price 3.18 | Shares 10,000
Buy 8 Dec 2022
Value US$115,804.00 | Price 2.10 | Shares 55,250
Sale 1 Jul 2022
Value US$74,525.76 | Price 18.32 | Shares 4,068
Sale 1 Jul 2022
Value US$163,245.60 | Price 18.45 | Shares 8,848
Sale 1 Jul 2022
Value US$15,504.72 | Price 18.48 | Shares 839
Sale 30 Jun 2022
Value US$203,368.98 | Price 19.01 | Shares 10,698
Sale 30 Jun 2022
Value US$102,932.18 | Price 19.37 | Shares 5,314
Planned sale 4 Apr 2022
Value US$300,395.00 | Price 30.04 | Shares 10,000
Planned sale 1 Apr 2022
Value US$95,700.00 | Price 29.00 | Shares 3,300
Planned sale 1 Apr 2022
Value US$95,700.00 | Price 29.00 | Shares 3,300
Planned sale 1 Apr 2022
Value US$95,700.00 | Price 29.00 | Shares 3,300
Planned sale 1 Apr 2022
Value US$95,700.00 | Price 29.00 | Shares 3,300
Planned sale 1 Apr 2022
Value US$95,700.00 | Price 29.00 | Shares 3,300
Planned sale 1 Apr 2022
Value US$95,700.00 | Price 29.00 | Shares 3,300
Planned sale 1 Jun 2021
Value US$82,299.79 | Price 33.19 | Shares 2,480
Planned sale 1 Jun 2021
Value US$17,720.51 | Price 34.08 | Shares 520
Planned sale 1 Apr 2021
Value US$59,253.15 | Price 35.04 | Shares 1,691
Planned sale 1 Apr 2021
Value US$47,027.79 | Price 35.93 | Shares 1,309
Planned sale 10 Mar 2021
Value US$104,675.86 | Price 35.09 | Shares 2,983
Planned sale 10 Mar 2021
Value US$83,313.42 | Price 35.11 | Shares 2,373
Planned sale 9 Mar 2021
Value US$65,380.32 | Price 36.32 | Shares 1,800
Planned sale 9 Mar 2021
Value US$184,788.75 | Price 35.42 | Shares 5,217
Planned sale 9 Mar 2021
Value US$58,556.06 | Price 36.33 | Shares 1,612
Planned sale 9 Mar 2021
Value US$119,994.83 | Price 35.42 | Shares 3,388
Planned sale 9 Mar 2021
Value US$64,836.00 | Price 36.02 | Shares 1,800
Planned sale 9 Mar 2021
Value US$202,857.21 | Price 35.42 | Shares 5,727
Planned sale 8 Mar 2021
Value US$3,500.00 | Price 35.00 | Shares 100
Planned sale 1 Mar 2021
Value US$101,617.80 | Price 33.87 | Shares 3,000
Planned sale 24 Feb 2021
Value US$10,770.65 | Price 35.55 | Shares 303
Planned sale 24 Feb 2021
Value US$168,658.52 | Price 34.70 | Shares 4,860
Planned sale 24 Feb 2021
Value US$162,962.88 | Price 33.69 | Shares 4,837
Planned sale 24 Feb 2021
Value US$3,842.92 | Price 35.58 | Shares 108
Planned sale 24 Feb 2021
Value US$85,315.12 | Price 34.64 | Shares 2,463
Planned sale 24 Feb 2021
Value US$81,774.96 | Price 33.67 | Shares 2,429
Planned sale 24 Feb 2021
Value US$48,544.44 | Price 34.67 | Shares 1,400
Planned sale 24 Feb 2021
Value US$53,984.80 | Price 33.74 | Shares 1,600
Planned sale 11 Feb 2021
Value US$51,238.43 | Price 35.43 | Shares 1,446
Planned sale 11 Feb 2021
Value US$50,542.06 | Price 35.39 | Shares 1,428
Planned sale 10 Feb 2021
Value US$84,825.49 | Price 35.20 | Shares 2,410
Planned sale 10 Feb 2021
Value US$68,097.16 | Price 35.28 | Shares 1,930
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-16 2025-12-15 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
90,407 +3.6%
315.92
US$4,220,053 		90,407 +3.6% 315.92 US$4,220,053
2025-12-16 2025-12-15 B Purchase
3.5
Shenouda Maged

Chief Financial Officer

Officer
83,255 -1.6%
447.83
US$4,586,391 		83,255 -1.6% 447.83 US$4,586,391
2025-11-06 2025-11-05 B Purchase
3.5
Shenouda Maged

Chief Financial Officer

Officer
64,139 -30.4%
134.32
US$2,216,325 		64,139 -30.4% 134.32 US$2,216,325
2025-11-06 2025-11-05 B Purchase
3.4
Ence Chuck

CAO and COO

Officer
136,000 +50.8%
2.20
US$299,200 		136,000 +50.8% 2.20 US$299,200
2025-11-06 2025-11-05 B Purchase
3.9
Kelly Paul Edward

Chief Operating Officer

Executive Director
90,000 +21.8%
2.20
US$198,000 		90,000 +21.8% 2.20 US$198,000
2025-11-06 2025-11-05 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
272,500 +27.3%
2.20
US$599,500 		272,500 +27.3% 2.20 US$599,500
2025-08-28 2025-08-28 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
55,976 +5.9%
0.74
US$41,422 		55,976 +5.9% 0.74 US$41,422
2025-08-28 2025-08-27 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
129,455 +15.9%
0.67
US$86,735 		129,455 +15.9% 0.67 US$86,735
2025-08-28 2025-08-26 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
80,545 +11.0%
0.62
US$49,938 		80,545 +11.0% 0.62 US$49,938
2025-05-20 2025-05-20 B Purchase
3.5
Shenouda Maged

Chief Financial Officer

Officer
60,000 +26.3%
0.52
US$31,422 		60,000 +26.3% 0.52 US$31,422
2025-05-20 2025-05-20 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
147,686 +25.2%
0.56
US$82,246 		147,686 +25.2% 0.56 US$82,246
2025-05-20 2025-05-19 B Purchase
3.5
Shenouda Maged

Chief Financial Officer

Officer
90,000 +65.1%
0.49
US$43,686 		90,000 +65.1% 0.49 US$43,686
2025-05-20 2025-05-19 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
30,000 +5.4%
0.50
US$14,994 		30,000 +5.4% 0.50 US$14,994
2025-05-20 2025-05-16 B Purchase
3.5
Shenouda Maged

Chief Financial Officer

Officer
50,000 +56.6%
0.44
US$22,100 		50,000 +56.6% 0.44 US$22,100
2025-05-20 2025-05-16 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
172,314 +44.9%
0.45
US$77,472 		172,314 +44.9% 0.45 US$77,472
2025-05-20 2025-05-16 B Purchase
3.9
Kelly Paul Edward

Chief Operating Officer

Executive Director
200,000 +94.2%
0.43
US$86,060 		200,000 +94.2% 0.43 US$86,060
2025-05-20 2025-05-16 B Purchase
3.4
Ence Chuck

CA and CO

Officer
228,961 +587.5%
0.45
US$103,330 		228,961 +587.5% 0.45 US$103,330
2024-09-11 2024-09-11 B Purchase
3.5
Shenouda Maged

Chief Financial Officer

Officer
24,120 +37.6%
2.95
US$71,154 		24,120 +37.6% 2.95 US$71,154
2024-09-11 2024-09-11 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
51,407 +15.5%
2.99
US$153,707 		51,407 +15.5% 2.99 US$153,707
2024-09-11 2024-09-10 B Purchase
3.5
Shenouda Maged

Chief Financial Officer

Officer
21,118 +49.0%
2.73
US$57,652 		21,118 +49.0% 2.73 US$57,652
2024-09-11 2024-09-10 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
33,014 +11.0%
2.75
US$90,788 		33,014 +11.0% 2.75 US$90,788
2024-09-11 2024-09-09 B Purchase
3.5
Shenouda Maged

Chief Financial Officer

Officer
8,194 +23.5%
2.55
US$20,895 		8,194 +23.5% 2.55 US$20,895
2024-09-11 2024-09-09 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
55,579 +22.8%
2.71
US$150,619 		55,579 +22.8% 2.71 US$150,619
2024-09-11 2024-09-09 B Purchase
3.9
Kelly Paul Edward
Non-Executive Director
25,000 +13.3%
2.59
US$64,750 		25,000 +13.3% 2.59 US$64,750
2024-09-11 2024-09-09 B Purchase
1.6
CASAMENTO CHARLES J
Non-Executive Director
13,000 +inf%
2.56
US$33,280 		13,000 +inf% 2.56 US$33,280
2024-02-20 2024-02-20 PrS Proposed sale
0.8
O'Gorman Cedric

Officer

Officer
74,999
5.90
US$442,494 		74,999 5.90 US$442,494
2024-01-31 2024-01-31 B Purchase
3.4
Ence Chuck

CA and CO

Officer
13,670 +54.0%
4.05
US$55,429 		13,670 +54.0% 4.05 US$55,429
2024-01-31 2024-01-31 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
27,460 +12.7%
4.00
US$109,752 		27,460 +12.7% 4.00 US$109,752
2024-01-31 2024-01-31 B Purchase
3.5
Shenouda Maged

Chief Financial Officer

Officer
6,875 +24.5%
4.06
US$27,943 		6,875 +24.5% 4.06 US$27,943
2024-01-31 2024-01-30 B Purchase
3.4
Ence Chuck

CA and CO

Officer
14,500 +134.3%
3.87
US$56,053 		14,500 +134.3% 3.87 US$56,053
2024-01-31 2024-01-30 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
40,999 +23.4%
3.90
US$159,949 		40,999 +23.4% 3.90 US$159,949
2024-01-31 2024-01-30 B Purchase
3.5
Shenouda Maged

Chief Financial Officer

Officer
15,000 +115.1%
3.89
US$58,323 		15,000 +115.1% 3.89 US$58,323
2024-01-31 2024-01-29 B Purchase
3.4
Ence Chuck

CA and CO

Officer
10,800 +inf%
3.65
US$39,438 		10,800 +inf% 3.65 US$39,438
2024-01-31 2024-01-29 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
31,541 +21.9%
3.71
US$117,036 		31,541 +21.9% 3.71 US$117,036
2024-01-31 2024-01-29 B Purchase
3.5
Shenouda Maged

Chief Financial Officer

Officer
10,800 +484.7%
3.65
US$39,450 		10,800 +484.7% 3.65 US$39,450
2023-05-24 2023-05-23 B Purchase
0.8
O'Gorman Cedric

Chief Medical Officer

Officer
10,000 +8264.5%
3.18
US$31,800 		10,000 +8264.5% 3.18 US$31,800
2022-12-12 2022-12-08 B Purchase
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
55,250 +62.2%
2.10
US$115,804 		55,250 +62.2% 2.10 US$115,804
2022-07-05 2022-07-01 S Sale
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
4,068 -4.4%
18.32
US$74,526 		4,068 -4.4% 18.32 US$74,526
2022-07-05 2022-07-01 S Sale
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
8,848 -8.7%
18.45
US$163,246 		8,848 -8.7% 18.45 US$163,246
2022-07-05 2022-07-01 S Sale
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
839 -0.8%
18.48
US$15,505 		839 -0.8% 18.48 US$15,505
2022-07-05 2022-06-30 S Sale
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
10,698 -10.8%
19.01
US$203,369 		10,698 -10.8% 19.01 US$203,369
2022-07-05 2022-06-30 S Sale
3.8
TRAVERSA SERGIO

Chief Executive Officer

Executive Director
5,314 -5.1%
19.37
US$102,932 		5,314 -5.1% 19.37 US$102,932
2022-04-05 2022-04-04 PlS Planned sale
3.9
Kelly Paul Edward
Non-Executive Director
10,000 -5.1%
30.04
US$300,395 		10,000 -5.1% 30.04 US$300,395
2022-04-05 2022-04-01 PlS Planned sale
1.6
CASAMENTO CHARLES J
Non-Executive Director
3,300 -100.0%
29.00
US$95,700 		3,300 -100.0% 29.00 US$95,700
2022-04-05 2022-04-01 PlS Planned sale
1.6
CASAMENTO CHARLES J
Non-Executive Director
3,300 -50.0%
29.00
US$95,700 		3,300 -50.0% 29.00 US$95,700
2022-04-05 2022-04-01 PlS Planned sale
1.6
CASAMENTO CHARLES J
Non-Executive Director
3,300 -33.3%
29.00
US$95,700 		3,300 -33.3% 29.00 US$95,700
2022-04-05 2022-04-01 PlS Planned sale
1.6
CASAMENTO CHARLES J
Non-Executive Director
3,300 -25.0%
29.00
US$95,700 		3,300 -25.0% 29.00 US$95,700
2022-04-05 2022-04-01 PlS Planned sale
1.6
CASAMENTO CHARLES J
Non-Executive Director
3,300 -20.0%
29.00
US$95,700 		3,300 -20.0% 29.00 US$95,700
2022-04-05 2022-04-01 PlS Planned sale
1.6
CASAMENTO CHARLES J
Non-Executive Director
3,300 -16.7%
29.00
US$95,700 		3,300 -16.7% 29.00 US$95,700
2021-06-02 2021-06-01 PlS Planned sale
1.6
CASAMENTO CHARLES J
Non-Executive Director
2,480 -26.3%
33.19
US$82,300 		2,480 -26.3% 33.19 US$82,300
2021-06-02 2021-06-01 PlS Planned sale
1.6
CASAMENTO CHARLES J
Non-Executive Director
520 -5.2%
34.08
US$17,721 		520 -5.2% 34.08 US$17,721
2021-04-05 2021-04-01 PlS Planned sale
1.6
CASAMENTO CHARLES J
Non-Executive Director
1,691 -11.5%
35.04
US$59,253 		1,691 -11.5% 35.04 US$59,253
2021-04-05 2021-04-01 PlS Planned sale
1.6
CASAMENTO CHARLES J
Non-Executive Director
1,309 -8.2%
35.93
US$47,028 		1,309 -8.2% 35.93 US$47,028
2021-03-11 2021-03-10 PlS Planned sale
3.8
TRAVERSA SERGIO

CEO

Executive Director
2,983 -3.3%
35.09
US$104,676 		2,983 -3.3% 35.09 US$104,676
2021-03-10 2021-03-10 PlS Planned sale
3.5
Shenouda Maged

CFO

Officer
2,373 -51.6%
35.11
US$83,313 		2,373 -51.6% 35.11 US$83,313
2021-03-11 2021-03-09 PlS Planned sale
3.8
TRAVERSA SERGIO

CEO

Executive Director
1,800 -1.9%
36.32
US$65,380 		1,800 -1.9% 36.32 US$65,380
2021-03-11 2021-03-09 PlS Planned sale
3.8
TRAVERSA SERGIO

CEO

Executive Director
5,217 -5.3%
35.42
US$184,789 		5,217 -5.3% 35.42 US$184,789
2021-03-11 2021-03-09 PlS Planned sale
3.9
Kelly Paul Edward
Non-Executive Director
1,612 -1.0%
36.33
US$58,556 		1,612 -1.0% 36.33 US$58,556
2021-03-11 2021-03-09 PlS Planned sale
3.9
Kelly Paul Edward
Non-Executive Director
3,388 -2.0%
35.42
US$119,995 		3,388 -2.0% 35.42 US$119,995
2021-03-10 2021-03-09 PlS Planned sale
3.5
Shenouda Maged

CFO

Officer
1,800 -28.1%
36.02
US$64,836 		1,800 -28.1% 36.02 US$64,836
2021-03-10 2021-03-09 PlS Planned sale
3.5
Shenouda Maged

CFO

Officer
5,727 -47.2%
35.42
US$202,857 		5,727 -47.2% 35.42 US$202,857
2021-03-10 2021-03-08 PlS Planned sale
3.5
Shenouda Maged

CFO

Officer
100 -0.8%
35.00
US$3,500 		100 -0.8% 35.00 US$3,500
2021-03-02 2021-03-01 PlS Planned sale
1.6
CASAMENTO CHARLES J
Non-Executive Director
3,000 -15.8%
33.87
US$101,618 		3,000 -15.8% 33.87 US$101,618
2021-02-26 2021-02-24 PlS Planned sale
3.8
TRAVERSA SERGIO

CEO

Executive Director
303 -0.3%
35.55
US$10,771 		303 -0.3% 35.55 US$10,771
2021-02-26 2021-02-24 PlS Planned sale
3.8
TRAVERSA SERGIO

CEO

Executive Director
4,860 -5.2%
34.70
US$168,659 		4,860 -5.2% 34.70 US$168,659
2021-02-26 2021-02-24 PlS Planned sale
3.8
TRAVERSA SERGIO

CEO

Executive Director
4,837 -4.9%
33.69
US$162,963 		4,837 -4.9% 33.69 US$162,963
2021-02-26 2021-02-24 PlS Planned sale
3.9
Kelly Paul Edward
Non-Executive Director
108 -0.1%
35.58
US$3,843 		108 -0.1% 35.58 US$3,843
2021-02-26 2021-02-24 PlS Planned sale
3.9
Kelly Paul Edward
Non-Executive Director
2,463 -1.4%
34.64
US$85,315 		2,463 -1.4% 34.64 US$85,315
2021-02-26 2021-02-24 PlS Planned sale
3.9
Kelly Paul Edward
Non-Executive Director
2,429 -1.4%
33.67
US$81,775 		2,429 -1.4% 33.67 US$81,775
2021-02-26 2021-02-24 PlS Planned sale
3.5
Shenouda Maged

CFO

Officer
1,400 -38.6%
34.67
US$48,544 		1,400 -38.6% 34.67 US$48,544
2021-02-26 2021-02-24 PlS Planned sale
3.5
Shenouda Maged

CFO

Officer
1,600 -30.6%
33.74
US$53,985 		1,600 -30.6% 33.74 US$53,985
2021-02-16 2021-02-11 PlS Planned sale
3.8
TRAVERSA SERGIO

CEO

Executive Director
1,446 -1.6%
35.43
US$51,238 		1,446 -1.6% 35.43 US$51,238
2021-02-16 2021-02-11 PlS Planned sale
3.5
Shenouda Maged

CFO

Officer
1,428 -39.1%
35.39
US$50,542 		1,428 -39.1% 35.39 US$50,542
2021-02-10 2021-02-10 PlS Planned sale
3.5
Shenouda Maged

CFO

Officer
2,410 -52.0%
35.20
US$84,825 		2,410 -52.0% 35.20 US$84,825
2021-02-10 2021-02-10 PlS Planned sale
3.8
TRAVERSA SERGIO

CEO

Executive Director
1,930 -2.1%
35.28
US$68,097 		1,930 -2.1% 35.28 US$68,097
Explore more

More insider trading research around Relmada Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America